Stay updated on Efficacy of Rifaximin with NAC in IBS-D Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.

Latest updates to the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s footer updated the displayed software/version revision from **v3.5.2** to **v3.5.3**. This represents an administrative release or UI update rather than a change to the clinical trial details.SummaryDifference0.0%

- Check18 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.4.3 added and Revision: v3.4.2 removed. No visible changes to study content or functionality are indicated.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice and the older Revision: v3.4.1 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check90 days agoChange DetectedA government funding notice was added and the page revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Efficacy of Rifaximin with NAC in IBS-D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.